Health Technology

Paradigm Oral Health Announces Acquisition by BlackRock Long Term Private Capital

Paradigm Oral

Paradigm Oral Health a leading oral surgery and digital dentistry platform announced that BlackRock Long Term Private Capital has entered into a definitive agreement to acquire a majority interest in the company from shareholders including InTandem Capital Partners. LTPC will partner with Paradigm’s executive leadership team, led by founder and CEO Dr. David Rallis, to support the company’s continued expansion and strategic growth plans.

Founded in 2018, Paradigm has developed an industry-leading model designed to attract and retain best-in-class surgeons focused on delivering the highest quality of oral health care and dental implant surgery while fostering a medically-driven, patient-friendly culture of excellence. The company partners with leading oral surgery groups in markets across the United States, allowing them to maintain their unique brand identity while operating on the same platform. Paradigm’s proprietary practice management technology, Paragon, utilizes cutting-edge technology and data analytics to provide and store proprietary information and intelligence generated by the business, leading to enhanced performance as well as increased patient and provider satisfaction. Today, Paradigm and its team of over 100 surgeon partners provide patient care in 75 state-of-the-art facilities throughout the United States.

We are pleased to invest in Paradigm, which has established itself as an industry defining platform for the development and delivery of next-generation oral health solutions. Through its focus on providing superior clinical care, advanced technology, and continued training and education to its surgeon partners, the company is well positioned for long-term growth. We look forward to partnering with Dr. David Rallis and the entire Paradigm team.”

Colm Lanigan, Head of BlackRock LTPC, Americas

David Rallis, DDS, MD, and CEO of Paradigm Oral Health, commented, “Paradigm is advancing oral surgical outcomes and patient experience through a culture that places the needs of the patient first. At Paradigm, we validate our clinical performance through a proprietary data ecosystem and use data to reinforce our culture of excellence and accountability. Through innovation, and the rapid adoption of technology, we continue to set the standard for dental implant surgery. Aligning our company with world-class partners, first InTandem Capital and now BlackRock LTPC, has allowed Paradigm to emerge as a leader. We are humbled by the opportunity to partner with BlackRock LTPC, and excited to work with Colm Lanigan and his team as we continue to advance Paradigm as the global leader in oral surgery.”

Elliot Cooperstone, Managing Partner of InTandem Capital Partners, Paradigm’s financial sponsor since 2019, commented, “InTandem Capital invests in healthcare companies that are local leaders with the ambition and potential to become a national powerhouse. Dr. David Rallis and the leadership team at Paradigm embraced our playbook for accelerated growth with amazing skill and dedication. Our deep trust in each other has allowed our partnership to flourish. My colleagues and I wish David and the Paradigm team the very best as they build on their well-deserved position as the country’s leading oral health company.”

Paradigm is BlackRock LTPC’s sixth investment to date and its fourth investment in North America.

Houlihan Lokey acted as financial advisor and Goodwin Procter acted as legal advisor to Paradigm. Simpson Thacher acted as legal advisor to Blackrock LTPC.

About Paradigm Oral Health
Paradigm Oral Health is the preeminent provider of oral surgery. Paradigm’s uniqueness comes from their ability to hire the most elite oral surgeons in the country and train them on their proprietary platform of excellence. Paradigm Oral Health continues to revolutionize and reinvent implant surgery through their ongoing technology and digital work-flow advancements. With a passion for excellence, Paradigm embraces every opportunity to meet the needs of their patients and referring dentists. 

About BlackRock LTPC
BlackRock LTPC is an innovative private equity strategy focused on investing in high-quality businesses and value creation through active collaboration with management teams. The strategy's flexible duration and prudent approach to leverage preserve optionality for growth and help enable compounded capital appreciation. LTPC's team of 23 professionals are based in New York and London and invest across North America and Western Europe. LTPC is backed by BlackRock, Inc., which manages $320 billion in alternative investments and commitments on behalf of clients worldwide as of June 30, 2022. 

About InTandem Capital Partners
InTandem Capital Partners is a private equity firm that invests in and helps accelerate the growth of select healthcare services companies. Its goal is to build excellent businesses of significant value working collaboratively with its management team partners. InTandem is comprised of former business executives and experienced investors, and is uniquely qualified to provide strategic, acquisition and operating expertise to help companies significantly increase their value over time. InTandem provides active support to the management of its portfolio companies directly and leverages its network of industry executives to augment its capabilities. 

Spotlight

Spotlight

Related News

Healthcare Analytics

GE HealthCare Releases Sustainability Report, Shares Future Goals

GE HealthCare | September 25, 2023

First Sustainability Report since January 2023 showcases the company’s commitment to creating a world with no healthcare limits Report shows reduced operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 Strong leadership focus on sustainability efforts and ESG with a cross-functional ESP GE HealthCare has released its inaugural Sustainability Report, marking its commitment to environmental, social, and governance (ESG) practices since becoming an independent company in January 2023. The report highlights the reduction of operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 and outlines the company's dedication to ESG principles and sustainability. GE HealthCare recognizes the importance of sustainability and corporate responsibility in the healthcare industry. The report reflects the company's dedication to creating a world where healthcare knows no limits and its commitment to environmental and social impact. ESG Program Leader at GE HealthCare, Kelvin Sanborn, stated, GE HealthCare recognizes the global significance of fulfilling our purpose and delivering on our objectives and is pleased to have reduced our operational GHG emissions by 27% versus our 2019 baseline. With our broad ESG strategy and priorities in mind, we are carrying out a climate risk assessment that will inform our climate transition plan, and developing a net zero roadmap for Scope 1, 2, and 3 GHG emissions. [Source: Business Wire] Key Highlights from the Company's Inaugural Sustainability Report: Environmental Impact Since 2019, reduced GHG emissions by 27% with goals of 50% reduction by 2030 and net zero by 2050 Registered with Science Based Targets Initiative Committed to decarbonizing the healthcare sector Social Impact Established cultural operating principles Planned GE Healthcare Foundation for philanthropy Appointed chief diversity, equity, and inclusion officer Governance and Accountability Strong corporate governance as a stand-alone public company Relaunched Code of Conduct with high employee engagement Joined UN Global Compact to support sustainable development goals GE HealthCare conducted an ESG materiality assessment, defining five key focus areas for its sustainability strategy. These include expanding healthcare access, fostering diversity and inclusion, reducing greenhouse gas emissions, promoting the circular economy, and enhancing patient data cybersecurity. The report outlines the company's long-term ESG objectives and progress toward previous goals. It is preparing to release an updated task force on climate-related financial disclosures (TCFD) report once its climate risk assessment is finalized. Furthermore, the company has scheduled a materiality assessment update for 2024. In parallel, GE HealthCare is exploring the expansion of Reporting Standards for its ESG disclosures and evaluating how its objectives align with the United Nations Sustainable Development Goals (UN SDGs). After conducting an ESG materiality assessment before its spin-off, the company has pinpointed five vital areas for its sustainability strategy. These priorities, underscored by the company's core innovation, product quality, and integrity principles, encompass the following: Expanding global healthcare access by ensuring underserved populations have better healthcare opportunities; promoting a culture of inclusion and diversity; mitigating its climate impact through concerted efforts; facilitating equipment and prioritizing patient data security and cybersecurity by adhering to standardized data privacy and security practices based on global regulations such as the EU GDPR.

Read More

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology, Digital Healthcare

Applications Open for Johnson & Johnson's Second Health Equity Innovation Challenge

PR Newswire | October 04, 2023

Johnson & Johnsonannounced applications for the 2023 - 2024 Health Equity Innovation Challenge are officially open in five U.S. cities: Atlanta, Chicago, Los Angeles, New York City and Philadelphia. These geographic areas were selected due to demonstrated need for healthcare education, access and care. Created in 2021 as a part of Johnson & Johnson's commitment to help eradicate the public health threats of racial and social injustices, the Challenge aims to support healthcare solutions developed by local entrepreneurs, start-ups and community-based organizations that are working to advance health equity among communities of color. "At the heart of our commitment to health equity is a desire to create a world in which access to care, quality of care and health outcomes isn't determined by the color of a person's skin," says Howard Reid, Global Head, Global Public Health and Social Impact at Johnson & Johnson. The Health Equity Innovation Challenge shines a light on health inequities and supports innovators at the local level to create solutions that empower individuals of color and strengthen our health systems. [Source: PR Newswire] With applications open through November 6, the Health Equity Innovation Challenge invites local innovators, entrepreneurs and community-based organizations to submit their ideas on how to prevent and treat illnesses disproportionately affecting communities of color, enhance equitable access to healthcare, stimulate diversity in science, advocate for more trusted community-based healthcare, and promote health equity through community engagement and education. An independent panel of renowned public health and health equity experts with diverse experience in healthcare delivery, advocacy, entrepreneurship and academia will review the applications. The panel includes Cato T. Laurencin, M.D., Ph.D.; Eddie Martinez; HEIC Chairperson Helene Gayle, M.D.; Kathryn Finney; Kiera Smalls; and Uché Blackstock, M.D. In addition to the panel of expert judges, select individuals appointed by the Challenge's academic partner, Spelman College, will review and screen the applications. In 2024, Johnson & Johnson will grant five Awardees up to $75,000 each in seed funding to further the impact of their innovations. Awardees will also have the opportunity to be mentored by industry leaders, gain visibility for their work and have access to the Johnson & Johnson Innovation – JLABS ecosystem, which provides educational programming, and networking opportunities. "Johnson & Johnson is committed to cultivating solutions that help close the racial health gap," says Reid. "We know that those closest to the challenges are often best positioned to create the most effective solutions. We are excited to accelerate innovative approaches that result in healthier outcomes for people of color through this Challenge."

Read More